Under construction – not a live service
Sign in

Liver and biliary tract cancer

Current status: Treatable, not yet curable

Cancers of the liver and of the bile ducts, the tubes that carry bile, a digestive juice made by the liver, to the small intestine. There may be no signs early on. Signs can include yellow skin and eyes, itchy skin, tummy pain or weight loss without trying. If liver cancer is found early, is small and has not spread, surgery may remove it. If it cannot be cured, treatment aims to limit the cancer and its symptoms. Liver cancer is more common after 60 and in men, and is linked to hepatitis, scarring of the liver (cirrhosis), heavy drinking and being overweight.

Read more about liver and biliary tract cancer
Where research stands todayUpdated 14 Nov 2026

Trial-stage treatments and research studies you can join

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsUnited States, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 2Taking people
    Tests zanzalintinib with durvalumab and tremelimumab for advanced liver cancer

    Tests zanzalintinib with immunotherapy drugs in adults with unresectable liver cancer.

    Pittsburgh, United StatesAlso San AntonioAge 18+
  2. Trial-stage treatmentPhase 1/2Taking people
    ASP546C for stomach, esophagus junction and pancreatic cancer and other solid tumors

    Tests ASP546C in adults with advanced gastric, gastroesophageal junction or pancreatic cancer.

    Atlanta, United StatesAlso Austin, Basking Ridge, Birmingham, Commack, Detroit, Durham, Fairfax, Grand Rapids, …Age 18+
  3. Trial-stage treatmentPhase 1Soon in United States
    Carfilzomib given into the liver for cancer that has spread there

    Tests carfilzomib through a liver pump in adults with cancer spread to the liver.

    Bethesda, United StatesAge 18 to 120
  4. Trial-stage treatmentTaking people
    Virtual reality headset tested for abdominal pain in digestive cancer patients

    Tests virtual reality headsets for abdominal pain in adults with digestive tract cancers.

    Los Angeles, United StatesAge 18 to 99
  5. Trial-stage treatmentTaking people
    Radiation Device Treatment for Unremovable Liver Tumors

    Tests a radiation device placed inside tumors in adults with liver cancers.

    Houston, United StatesAge 19+
  6. Trial-stage treatmentPhase 1Taking people
    Tests PLN-101095 with pembrolizumab in adults with advanced solid tumors

    Tests PLN-101095, alone and with pembrolizumab, in adults with solid tumors that progressed on immunotherapy.

    Atlanta, United StatesAlso Austin, East Brunswick, Edmonds, Fairfax, Fort Worth, Grand Rapids, Houston, Lake Success, …Age 18+
  7. Trial-stage treatmentTaking people
    Tests a TheraBionic P1 device in adults with advanced liver cancer

    Tests a device in adults with advanced liver cancer after other treatments.

    Ann Arbor, United StatesAlso Bay City, Detroit, Flint, Houston, Lansing, Lapeer, Mount PleasantAge 22+
  8. Trial-stage treatmentPhase 1Taking people
    Tests ST-01156 in people with advanced solid tumors

    Tests a new drug, ST-01156, in adults with advanced solid tumors and certain cancers.

    Boston, United StatesAlso Duarte, Houston, Newport Beach, New YorkAge 16+
  9. Trial-stage treatmentPhase 1Taking people
    Testing KST-6051 in advanced cancers with a KRAS mutation

    Tests the safety of KST-6051 in adults with KRAS-mutant advanced solid tumors.

    Boston, United StatesAlso Fairfax, Houston, Los Angeles, Philadelphia, Salt Lake City, San Antonio, Sarasota, TampaAge 18+
  10. Trial-stage treatmentPhase 1Taking people
    Testing Lower Atezolizumab Doses Guided by Drug Levels in Cancer

    Tests adjusted atezolizumab dosing in adults with lung cancer or sarcoma.

    Bethesda, United StatesAge 18 to 120
  11. Trial-stage treatmentPhase 1/2Taking people
    Tests VS-7375 in adults with advanced solid tumors carrying a KRAS G12D mutation

    Tests the drug VS-7375, alone or combined, in adults with advanced KRAS G12D-mutated cancers.

    Ann Arbor, United StatesAlso Baltimore, Boston, Charlottesville, Fairfax, Houston, Los Angeles, Nashville, New York, …Age 18+
  12. Trial-stage treatmentPhase 2Taking people
    Tests visugromab with nivolumab and lenvatinib in advanced liver cancer after prior immunotherapy

    Tests visugromab with nivolumab and lenvatinib in adults with advanced liver cancer.

    Atlanta, United StatesAlso Boston, Irvine, Los Angeles, Orange, Peoria, Santa MonicaAge 18 to 100
  13. Trial-stage treatmentPhase 2Soon in United States
    Daraxonrasib for Biliary Tract Cancer That Has Returned and Carries a KRAS Mutation

    Tests daraxonrasib in adults with KRAS-mutant biliary tract cancer after first treatment.

    Baltimore, United StatesAge 18+
  14. Trial-stage treatmentPhase 2Taking people
    Tests lirafugratinib in solid tumors with an FGFR2 gene change

    Tests lirafugratinib in adults with FGFR2-changed solid tumors, not bile duct cancer.

    Boston, United StatesAlso Chicago, Houston, Jacksonville, New York, Phoenix, Rochester, TampaAge 18+
  15. Trial-stage treatmentTaking people
    Testing a Blood Test That Screens for Several Cancers at Once

    Tests a blood test screening for multiple cancers in adults aged 45-75 without cancer.

    Bethesda, United StatesAlso Chapel Hill, Charlottesville, Chesterfield, Cheyenne Wells, Cleveland, Clinton Township, Dearborn, Denver, …Age 45 to 75
  16. Trial-stage treatmentTaking people
    Microwave heat treatment guided by endoscopic ultrasound for advanced pancreatic or liver cancer

    Tests a microwave device that heats tumors, in adults with advanced pancreatic or liver cancer.

    Chicago, United StatesAlso Gilbert, Houston, Knoxville, Los Angeles, MorgantownAge 18+
  17. Trial-stage treatmentPhase 3Taking people
    Tests D07001 capsules with capecitabine in advanced biliary tract cancer

    Tests D07001 capsules plus capecitabine against placebo in adults with advanced bile duct cancer.

    Cleveland, United StatesAlso Dallas, Miami Beach, TucsonAge 18+
  18. Trial-stage treatmentPhase 2Taking people
    Tests sevabertinib in solid tumors with HER2 gene mutations

    Tests sevabertinib tablets in adults with solid tumors carrying HER2 mutations.

    Birmingham, United StatesAlso Boston, Cleveland, Detroit, Duarte, Farmington Hills, Fort Myers, Houston, Madison, …Age 18+
  19. Trial-stage treatmentPhase 2Soon in United States
    Tests a drug combination in advanced combined liver and bile duct cancer

    Tests tremelimumab, durvalumab, gemcitabine and cisplatin in adults with combined hepatocellular-cholangiocarcinoma.

    Birmingham, United StatesAge 18+
  20. Trial-stage treatmentPhase 1Taking people
    Tests LY4337713 in adults with advanced solid tumors that have high FAP protein

    Tests radioligand therapy LY4337713 in adults with certain advanced cancers that have high FAP protein.

    Boston, United StatesAlso Dallas, Detroit, Durham, Glen Burnie, Grand Rapids, Houston, Indianapolis, Madison, …Age 18+

Where treatment stands

Zanidatamab, on the EU list for this cancer, was first approved in the EU in June 2025.

Approved: 18

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 49

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 2

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 2

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.

Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 419 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for liver and bile duct cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in United States, for you and your family.

Liver and biliary tract cancer organisations in United States

  • National Cancer Institute – Cancer Information Service (CIS)

    NCI's contact center: information specialists answer cancer questions from patients, families and the public by phone, chat and email.

  • American Cancer Society

    Nationwide US nonprofit helping people who face cancer: research, patient services, early detection, treatment information and education, with a cancer helpline on its site.

  • American Liver Foundation

    National nonprofit promoting education, support and research for the prevention, treatment and cure of liver disease, including liver cancer.

  • Blue Faery (liver cancer / HCC association)

    HCC liver cancer charity: free private online patient/caregiver community, one-on-one support, free patient education materials and clinical trial information.

  • Cactus Cancer Society

    Young adult cancer resource and community: support programs for people diagnosed with cancer as young adults.

  • Cancer Hope Network

    Nonprofit providing free one-on-one support to cancer patients and families by matching them with trained volunteers who have had a similar experience.

  • Cancer Nation

    Survivor-led US cancer advocacy organization (formerly the National Coalition for Cancer Survivorship) working on quality cancer care and survivorship resources.

  • Cholangiocarcinoma Foundation

    Bile duct cancer patient support: one-to-one peer mentors, patient advocate contact, virtual support groups, newly-diagnosed kit, specialist finder and trial information.

  • Imerman Angels

    Nonprofit offering free one-on-one cancer support and personalized mentoring that connects cancer fighters, survivors and caregivers with someone who has been there.

  • Triage Cancer

    National nonprofit providing free education on legal and practical issues (insurance, employment, finances) for people with cancer and caregivers.

General support in United States

  • 988 Suicide & Crisis Lifeline

    US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.

  • MedlinePlus

    Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.

International organisations

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Treatments approved outside the EU

Medicines for liver and biliary tract cancer approved in the US or Japan that are not approved in the EU.

Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 6 uncertain matches are left out.

Check with your insurance

Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.

“Miracle cure” fact checker

Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 4

About liver and biliary tract cancer

Sources: NHS, MedlinePlus, NCI PDQ, Cancer Research UK

Cancers of the liver and of the bile ducts, the tubes that carry bile, a digestive juice made by the liver, to the small intestine. There may be no signs early on. Signs can include yellow skin and eyes, itchy skin, tummy pain or weight loss without trying. If liver cancer is found early, is small and has not spread, surgery may remove it. If it cannot be cured, treatment aims to limit the cancer and its symptoms. Liver cancer is more common after 60 and in men, and is linked to hepatitis, scarring of the liver (cirrhosis), heavy drinking and being overweight.

What is it?

The liver is a large organ in the upper right of the tummy. It helps digest food and filters out harmful substances. Bile ducts are tubes that carry bile, a digestive juice made by the liver, to the small intestine. Primary liver cancer starts in the liver itself; secondary liver cancer has spread there from another part of the body. Bile duct cancer (cholangiocarcinoma) is uncommon and can start in the ducts inside or outside the liver.

Anyone can get them. Liver cancer is more common after 60 and in men, and bile duct cancer after 65. Liver cancer is linked to hepatitis, cirrhosis (scarring of the liver), diabetes, heavy drinking, smoking and being overweight. Bile duct cancer is linked to ulcerative colitis, bile duct stones, liver flukes (a parasite) and cirrhosis. Having a parent, brother or sister who had primary liver cancer raises your risk.

The first signs

In the early stages there may be no signs, or signs that are hard to spot.

  • yellow skin or whites of the eyes (jaundice), and you may also have itchy skin, darker pee and paler poo than usual;
  • losing your appetite, or losing weight without trying;
  • tiredness, or feeling generally unwell or as if you have flu;
  • a high temperature, or feeling hot, cold or shivery;
  • feeling or being sick, or pain in the upper right of the tummy or in the right shoulder;
  • a lump or swelling in the tummy, or feeling full very quickly when you eat.

How doctors find out

Your family doctor may examine your tummy and do a blood test, then send you to a specialist. Tests can include blood tests, scans (ultrasound, CT or MRI) and a biopsy, where a small sample of cells is taken and checked for cancer. More tests, sometimes a small operation to look inside the tummy (laparoscopy), help the specialists find out the size of the cancer and how far it has spread. Results can take several weeks. A specialist nurse becomes your main contact.

Current treatment

Surgery or ablation if early; immunotherapy if advanced

Will it get worse?

It depends on where the cancer is, how big it is, whether it has spread and your general health. You may not have symptoms until the cancer is advanced, which makes it harder to treat. Advanced liver or bile duct cancer may not be curable. Treatment then aims to limit the cancer and its symptoms and help you live longer. You will be referred to a palliative care team.

Medicines: what helps, and what to watch for

Targeted medicines or immunotherapy may be used when surgery is not possible or the cancer has spread to another part of the body. Immunotherapy helps your immune system attack the cancer, and targeted medicines kill cancer cells or slow their growth. In bile duct cancer, you may have chemotherapy after surgery to help stop the cancer coming back, or to make it smaller and ease symptoms if you cannot have surgery. It can be given with radiotherapy, targeted medicines or immunotherapy. In liver cancer, chemotherapy is usually given into the blood vessels of the cancer (chemoembolisation).

Good to know:

  • Your team explains the benefits and side effects of each treatment and helps you manage them, including changes to your diet to help digestion;
  • You have regular check-ups during and after treatment, and you may also have tests and scans;
  • Tiredness is common during treatment and for some months after. Rest, together with gentle activity, can help.

Surgery, for some people

If the cancer is found early, is small and has not spread, surgery may remove it. For liver cancer this means removing part of the liver, or the whole liver followed by a transplant with a donated liver. For bile duct cancer, all or part of the bile duct is removed, often with parts of nearby organs. Recovery can take a long time. If liver cancer cannot be removed by surgery, it may be treated with heat (thermal ablation) or radiotherapy. In bile duct cancer, surgery can unblock or bypass a blockage in the bile duct or small intestine to help with jaundice and feeling or being sick.

Is there a cure?

Sometimes. In early liver cancer, a liver transplant, surgery or ablation can offer a chance of cure. When liver cancer is found early, surgery, a liver transplant or ablation can offer a chance of cure. If the cancer cannot be cured, treatment aims to limit the cancer and its symptoms and help you live longer.

See the 1,509 trials you can join

Median survival

About 16 months with modern first treatment, for advanced liver cancer

Measured in: Advanced hepatocellular carcinoma (the main liver cancer; not bile duct cancer), first treatment: the HIMALAYA trial (1,171 patients)

The figures behind it

Advanced hepatocellular carcinoma (the main liver cancer; not bile duct cancer): in the HIMALAYA trial (1,171 patients), median overall survival was 16.43 months with tremelimumab plus durvalumab vs 13.77 months with sorafenib, as stated in the NCI PDQ health professional summary. The same page says untreated people with advanced disease usually survive less than 6 months.